Related Experiment Videos
Tissue engineering of biological cardiovascular system surrogates
Catherine E Sarraf1, Andrew B Harris, Andrew D McCulloch
1Centre for Tissue Engineering Research, Department of Biomedical Sciences, University of Westminster, London, UK. sarrafc@wmin.ac.uk
Heart, Lung & Circulation
|December 15, 2005
Summary
Tissue engineering offers promising solutions for cardiovascular diseases in aging populations. Research explores creating durable, non-immunogenic biological substitutes for damaged tissues and blood vessels.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Cardiovascular Research
Background:
- Cardiovascular diseases are prevalent in aging global populations, particularly in industrialized nations.
- Elderly patients often require surgical grafts, but human-donated tissues are insufficient.
- Synthetic and tissue-engineered cardiovascular surrogates are being developed to address this need.
Purpose of the Study:
- To review current and novel concepts in tissue engineering for biological cardiovascular system surrogates.
- To highlight the challenges and potential of creating effective, durable, and biocompatible cardiovascular substitutes.
- To explore methods for mimicking physiological conditions in engineered cardiovascular tissues.
Main Methods:
- Review of existing literature on cardiovascular tissue engineering.
- Discussion of mechanical stress monitoring and application in cell culture (culture force monitor).
- Exploration of bioreactor systems for simulating physiological conditions (e.g., hydrostatic forces, mechanical parameters).
Main Results:
- Various composite materials (mechanical, biological, tissue-engineered) show potential as blood vessel substitutes.
- Tissue engineering aims to create neotissues that are effective, durable, non-thrombogenic, and non-immunogenic.
- Bioreactor systems can apply physiological stresses to engineered tissues, promoting cell alignment and mimicking native architecture.
Conclusions:
- Tissue engineering holds significant promise for developing advanced cardiovascular substitutes.
- Mimicking in vivo mechanical and hydrostatic forces is crucial for creating functional engineered cardiovascular tissues.
- Further research in bioreactor technology and material science is essential for clinical translation.